Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
21 September 2024 - 7:19AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a)
of
the Securities Exchange Act of 1934
(Amendment
No. )
| Filed
by the Registrant |
☒ |
| |
|
| Filed
by a Party other than the Registrant |
☐ |
Check
the appropriate box:
| ☐ |
Preliminary
Proxy Statement |
| |
|
| ☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| |
|
| ☐ |
Definitive
Proxy Statement |
| |
|
| ☒ |
Definitive
Additional Materials |
| |
|
| ☐ |
Soliciting
Material Pursuant to § 240.14a-12 |
INTERPACE
BIOSCIENCES, INC.
(Name
of Registrant as Specified in Its Charter)
Not
applicable
(Name
of Person(s) Filing Proxy Statement, if other than the registrant)
Payment
of Filing Fee (Check all boxes that apply):
| ☒ |
No
fee required. |
| |
|
| ☐ |
Fee
paid previously with preliminary materials. |
| |
|
| ☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Interpace Biosciences (QX) (USOTC:IDXG)
Historical Stock Chart
From Jan 2025 to Feb 2025
Interpace Biosciences (QX) (USOTC:IDXG)
Historical Stock Chart
From Feb 2024 to Feb 2025
